Literature DB >> 25825125

Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects.

Cecilia Camarda1, Paola Torelli, Rosolino Camarda, Iacopo Battaglini, Cesare Gagliardo, Roberto Monastero.   

Abstract

The aim of this study is to describe the frequency of isolated, subtle, neurological abnormalities (ISNAs) in a large population of neurologically and cognitively healthy subjects and to compare ISNAs to various types of MRI-detected cerebrovascular lesions and subcortical brain atrophy in different age classes. 907 subjects were selected from a large, prospective hospital-based study. At baseline neurological examination, 17 ISNAs were selected. Primitive reflexes were the most common ISNAs (35.8%), while dysphagia was the most rarely encountered (0.3%). Measures of small vessel disease, i.e., deep and subcortical white matter hyperintensity and lacunar infarcts as well as subcortical atrophy, were variously associated with ISNAs. In the adult group, the ISNAs were associated with hypertriglyceridemia, TIA, and subcortical lacunar infarcts, while in the elderly-old group they were associated with arterial hypertension, subcortical white matter hyperintensity, and subcortical atrophy. An increased risk of ISNAs was associated with lacunae and white matter hyperintensity in the parietal region. This study shows that white matter hyperintensity, lacunae, and subcortical atrophy are associated with an increased risk of ISNAs in cognitively and neurologically healthy aging subjects. ISNAs are not benign signs. Therefore, adults and elderly people presenting with ISNAs should have access to accurate history and diagnosis to prevent progression of small vessel disease and future neurological and cognitive disabilities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25825125     DOI: 10.1007/s00415-015-7716-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  53 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Changes in normal-appearing white matter precede development of white matter lesions.

Authors:  Marius de Groot; Benjamin F J Verhaaren; Renske de Boer; Stefan Klein; Albert Hofman; Aad van der Lugt; M Arfan Ikram; Wiro J Niessen; Meike W Vernooij
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

3.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

Authors:  I Appollonio; M Leone; V Isella; F Piamarta; T Consoli; M L Villa; E Forapani; A Russo; P Nichelli
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

4.  Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  J Neuropathol Exp Neurol       Date:  1990-05       Impact factor: 3.685

5.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Neurological examination in subjects over 65 years: an epidemiological survey.

Authors:  G Benassi; R D'Alessandro; R Gallassi; A Morreale; E Lugaresi
Journal:  Neuroepidemiology       Date:  1990       Impact factor: 3.282

8.  Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type.

Authors:  M J De Leon; S H Ferris; A E George; B Reisberg; I I Kricheff; S Gershon
Journal:  Neurobiol Aging       Date:  1980       Impact factor: 4.673

9.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Walter A Rocca; David S Knopman; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Gregory M Preboske; Vernon S Pankratz; Prashanthi Vemuri; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2014-09-04       Impact factor: 44.182

10.  Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.

Authors:  Alida A Gouw; Wiesje M van der Flier; Franz Fazekas; Elisabeth C W van Straaten; Leonardo Pantoni; Anna Poggesi; Domenico Inzitari; Timo Erkinjuntti; Lars O Wahlund; Gunhild Waldemar; Reinhold Schmidt; Philip Scheltens; Frederik Barkhof
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

View more
  2 in total

1.  Preoperative imaging findings in patients undergoing transcranial magnetic resonance imaging-guided focused ultrasound thalamotomy.

Authors:  Cesare Gagliardo; Roberto Cannella; Giuseppe Filorizzo; Patrizia Toia; Giuseppe Salvaggio; Giorgio Collura; Antonia Pignolo; Rosario Maugeri; Alessandro Napoli; Marco D'amelio; Tommaso Vincenzo Bartolotta; Maurizio Marrale; Gerardo Domenico Iacopino; Carlo Catalano; Massimo Midiri
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

2.  Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project.

Authors:  Antonella Marino Gammazza; Vincenzo Restivo; Roberta Baschi; Celeste Caruso Bavisotto; Angelo B Cefalù; Giulia Accardi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello; Roberto Monastero
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.